Cargando…

Drug-induced acute pancreatitis in a bodybuilder: a case report

BACKGROUND: Unregulated use of a variety of drugs and supplements by bodybuilders and athletes is common and can lead to severe adverse complications. Only a small proportion of acute pancreatitis cases are drug induced, and case reports are essential for identifying potential drug-related risks for...

Descripción completa

Detalles Bibliográficos
Autores principales: Safizadeh Shabestari, Seyed Ali, Ho, Samuel B., Chaudhary, Priyadarshini, Nathwani, Rahul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939103/
https://www.ncbi.nlm.nih.gov/pubmed/35313971
http://dx.doi.org/10.1186/s13256-022-03329-3
_version_ 1784672675500654592
author Safizadeh Shabestari, Seyed Ali
Ho, Samuel B.
Chaudhary, Priyadarshini
Nathwani, Rahul A.
author_facet Safizadeh Shabestari, Seyed Ali
Ho, Samuel B.
Chaudhary, Priyadarshini
Nathwani, Rahul A.
author_sort Safizadeh Shabestari, Seyed Ali
collection PubMed
description BACKGROUND: Unregulated use of a variety of drugs and supplements by bodybuilders and athletes is common and can lead to severe adverse complications. Only a small proportion of acute pancreatitis cases are drug induced, and case reports are essential for identifying potential drug-related risks for pancreatitis. Here we present the first case report published of acute pancreatitis linked to recreational use of anabolic–androgenic steroids, subcutaneous growth hormone, and clenbuterol in a previously healthy male after excluding all other causes of pancreatitis. CASE PRESENTATION: A 31-year-old Arab male bodybuilder presented with acute abdominal pain associated with nausea and sharp pain radiating to the back. The patient was not using tobacco or alcohol but was using multiple drugs related to bodybuilding, including anabolic–androgenic steroids, subcutaneous growth hormone, clenbuterol, and multiple vitamin supplements. Laboratory studies revealed a normal white blood cell count, elevated C-reactive protein, minimally elevated aspartate aminotransferase and total bilirubin with normal remaining liver tests, and elevated amylase and lipase. The patient had no hypertriglyceridemia or hypercalcemia, and had had no recent infections, abdominal procedures, trauma, or scorpion exposure. Imaging and laboratory investigations were negative for biliary disease and IgG4 disease. Abdominal computed tomography revealed hepatomegaly and diffuse thickening and edema of the body and tail of the pancreas with peripancreatic fat stranding. An abdominal ultrasound showed slight hepatomegaly with no evidence of cholelithiasis. Genetic testing for hereditary pancreatitis-related mutations was negative. A diagnosis of drug-induced acute pancreatitis was made, and he was treated with aggressive intravenous hydration and pain management. The patient has avoided further use of these drugs and supplements and had no further episodes of pancreatitis during 1 year of follow-up. CONCLUSIONS: This case describes a patient with drug-induced acute pancreatitis after the intake of anabolic–androgenic steroids, subcutaneous growth hormone, and clenbuterol, where all other common causes of acute pancreatitis were excluded. Clinicians should be alert to the possibility of drug-induced acute pancreatitis occurring in bodybuilders and athletes using similar drug combinations.
format Online
Article
Text
id pubmed-8939103
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89391032022-03-23 Drug-induced acute pancreatitis in a bodybuilder: a case report Safizadeh Shabestari, Seyed Ali Ho, Samuel B. Chaudhary, Priyadarshini Nathwani, Rahul A. J Med Case Rep Case Report BACKGROUND: Unregulated use of a variety of drugs and supplements by bodybuilders and athletes is common and can lead to severe adverse complications. Only a small proportion of acute pancreatitis cases are drug induced, and case reports are essential for identifying potential drug-related risks for pancreatitis. Here we present the first case report published of acute pancreatitis linked to recreational use of anabolic–androgenic steroids, subcutaneous growth hormone, and clenbuterol in a previously healthy male after excluding all other causes of pancreatitis. CASE PRESENTATION: A 31-year-old Arab male bodybuilder presented with acute abdominal pain associated with nausea and sharp pain radiating to the back. The patient was not using tobacco or alcohol but was using multiple drugs related to bodybuilding, including anabolic–androgenic steroids, subcutaneous growth hormone, clenbuterol, and multiple vitamin supplements. Laboratory studies revealed a normal white blood cell count, elevated C-reactive protein, minimally elevated aspartate aminotransferase and total bilirubin with normal remaining liver tests, and elevated amylase and lipase. The patient had no hypertriglyceridemia or hypercalcemia, and had had no recent infections, abdominal procedures, trauma, or scorpion exposure. Imaging and laboratory investigations were negative for biliary disease and IgG4 disease. Abdominal computed tomography revealed hepatomegaly and diffuse thickening and edema of the body and tail of the pancreas with peripancreatic fat stranding. An abdominal ultrasound showed slight hepatomegaly with no evidence of cholelithiasis. Genetic testing for hereditary pancreatitis-related mutations was negative. A diagnosis of drug-induced acute pancreatitis was made, and he was treated with aggressive intravenous hydration and pain management. The patient has avoided further use of these drugs and supplements and had no further episodes of pancreatitis during 1 year of follow-up. CONCLUSIONS: This case describes a patient with drug-induced acute pancreatitis after the intake of anabolic–androgenic steroids, subcutaneous growth hormone, and clenbuterol, where all other common causes of acute pancreatitis were excluded. Clinicians should be alert to the possibility of drug-induced acute pancreatitis occurring in bodybuilders and athletes using similar drug combinations. BioMed Central 2022-03-22 /pmc/articles/PMC8939103/ /pubmed/35313971 http://dx.doi.org/10.1186/s13256-022-03329-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Safizadeh Shabestari, Seyed Ali
Ho, Samuel B.
Chaudhary, Priyadarshini
Nathwani, Rahul A.
Drug-induced acute pancreatitis in a bodybuilder: a case report
title Drug-induced acute pancreatitis in a bodybuilder: a case report
title_full Drug-induced acute pancreatitis in a bodybuilder: a case report
title_fullStr Drug-induced acute pancreatitis in a bodybuilder: a case report
title_full_unstemmed Drug-induced acute pancreatitis in a bodybuilder: a case report
title_short Drug-induced acute pancreatitis in a bodybuilder: a case report
title_sort drug-induced acute pancreatitis in a bodybuilder: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939103/
https://www.ncbi.nlm.nih.gov/pubmed/35313971
http://dx.doi.org/10.1186/s13256-022-03329-3
work_keys_str_mv AT safizadehshabestariseyedali druginducedacutepancreatitisinabodybuilderacasereport
AT hosamuelb druginducedacutepancreatitisinabodybuilderacasereport
AT chaudharypriyadarshini druginducedacutepancreatitisinabodybuilderacasereport
AT nathwanirahula druginducedacutepancreatitisinabodybuilderacasereport